Skip to main content
. Author manuscript; available in PMC: 2011 Jul 12.
Published in final edited form as: Immunopharmacol Immunotoxicol. 2010 Jun;32(2):181–195. doi: 10.3109/08923970903369867

Figure 1.

Figure 1

Evidence-based modeling. Initial model components are determined from experimental data using Principal Component Analysis. Subsequently, model building follows an iterative process involving calibration from existing or new data, and validation from prediction of data. This process identifies both areas where a model is correct and where it is deficient relative to data and therefore must be corrected.